ROSEANN BENANTI: Open Payments
NPI 1780330902 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,675 in 134 payments from 18 companies in 2025. Trend: 2023 $1,228 · 2024 $1,603 · 2025 $20,675
Speaker / faculty: $15,525Food & beverage: $3,865Travel & lodging: $1,186Education: $99
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 62 | $18,832 |
| Janssen Biotech, Inc. | 18 | $620 |
| GENZYME CORPORATION | 2 | $242 |
| Janssen Scientific Affairs, LLC | 3 | $237 |
| ABBVIE INC. | 14 | $186 |
| Aimmune Therapeutics, Inc. | 6 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $105 |
| Phathom Pharmaceuticals, Inc. | 7 | $80 |
| Intercept Pharmaceuticals, Inc. | 4 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: REZDIFFRA, TREMFYA, DUPIXENT, RINVOQ, ZENPEP, VOQUEZNA, OCALIVA, ENTYVIO.
Industry payments across NJ — which companies pay providers there.
